ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alnylam Pharmaceuticals Announces Proposed Public Offering of Common Stock
January 15, 2019Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the commencement of an underwritten public offering of 5,000,000 shares of its common stock. -
Vir Biotechnology and Alnylam Pharmaceuticals Initiate Phase 1/2 Study of VIR-2218
November 28, 2018Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. announced the initiation of a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference (RNAi) therapeutic for the treatment ....... -
Will more pharmas oppose Trump after Merck CEO's resignation?
August 16, 2017Merck CEO Ken Frazier stepped down from President Donald Trump's manufacturing panel and getting a response from the president.
Pharma Sources Insight January 2025
